Form 8-K - Current report:
SEC Accession No. 0001193125-21-193361
Filing Date
2021-06-17
Accepted
2021-06-17 17:21:01
Documents
13
Period of Report
2021-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d164967d8k.htm   iXBRL 8-K 36074
2 EX-10.1 d164967dex101.htm EX-10.1 141517
  Complete submission text file 0001193125-21-193361.txt   338351

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blcm-20210615.xsd EX-101.SCH 3070
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blcm-20210615_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blcm-20210615_pre.xml EX-101.PRE 11408
6 EXTRACTED XBRL INSTANCE DOCUMENT d164967d8k_htm.xml XML 3455
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 211025846
SIC: 2834 Pharmaceutical Preparations